Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03303248 · ClinicalTrials.gov registry record · NA

Evaluation of Web-based Transition Education to Enhance Transition Readiness

A NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT03303248 is a NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease that has completed, run by University of Michigan. The registered enrollment target is 180 participants, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03303248, a NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adult congenital heart disease population.

Interventions

  • BEHAVIORAL Web-based Educational Intervention

Study Locations (1)

Michigan

  • C.S. Mott Children's Hospital - Ann Arbor

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2018-08-27
Est. Completion 2025-06-30
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03303248

The ClinicalTrials.gov registry entry for NCT03303248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (62% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Web-based Educational Intervention is the first listed.

NCT03303248 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03303248 about?

NCT03303248 is a clinical study titled "Evaluation of Web-based Transition Education to Enhance Transition Readiness". The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adult congenital heart disease population.

What is the current status of trial NCT03303248?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2018-08-27. Estimated completion is 2025-06-30.

What conditions does trial NCT03303248 study?

This clinical trial studies the following conditions: Congenital Heart Disease, Pediatric Congenital Heart Disease, Transition.

What interventions are being tested in trial NCT03303248?

The interventions under investigation include: Web-based Educational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03303248?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03303248 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.